Pliant Therapeutics (PLRX) Leases (2021 - 2025)
Historic Leases for Pliant Therapeutics (PLRX) over the last 5 years, with Q3 2025 value amounting to $24.8 million.
- Pliant Therapeutics' Leases fell 1162.04% to $24.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year decrease of 1162.04%. This contributed to the annual value of $27.2 million for FY2024, which is 214962.84% up from last year.
- According to the latest figures from Q3 2025, Pliant Therapeutics' Leases is $24.8 million, which was down 1162.04% from $25.6 million recorded in Q2 2025.
- Pliant Therapeutics' 5-year Leases high stood at $28.1 million for Q3 2024, and its period low was $1.2 million during Q4 2023.
- In the last 5 years, Pliant Therapeutics' Leases had a median value of $6.1 million in 2022 and averaged $12.7 million.
- In the last 5 years, Pliant Therapeutics' Leases tumbled by 7766.51% in 2023 and then skyrocketed by 214962.84% in 2024.
- Quarter analysis of 5 years shows Pliant Therapeutics' Leases stood at $6.3 million in 2021, then dropped by 14.34% to $5.4 million in 2022, then crashed by 77.67% to $1.2 million in 2023, then surged by 2149.63% to $27.2 million in 2024, then fell by 8.99% to $24.8 million in 2025.
- Its Leases stands at $24.8 million for Q3 2025, versus $25.6 million for Q2 2025 and $26.4 million for Q1 2025.